GlobalData anticipates that seven products in the late-stage pipeline will enter the migraine market in the 7MM during the forecast period, which will be another driver of growth for the market.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,